Combination Therapy of Solvent-free Abraxane and the Targeted … - PharmaLive.com (press release)
Published by Google Inc. June 1st, 2008 in Google FDA News, Regulatory AffairsCombination Therapy of Solvent-free Abraxane and the Targeted ... PharmaLive.com (press release), PA - The US Food and Drug Administration (FDA) approved ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) ... ASCO AT A GLANCE: Genetic Research A Focus Of Cancer Meeting Erbitux OK for colorectal cancer patients with genetic marker Imclone Gets Targeted |